# Severe Erythema Multiforme - CORTICO

> **NCT06266221** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 96 (estimated)

## Conditions studied

- Erythema Multiforme

## Interventions

- **DRUG:** Prednisone 20 Mg
- **DRUG:** Oral Placebo
- **DRUG:** Methylprednisolone 120 Mg
- **DRUG:** IV Placebo

## Key facts

- **NCT ID:** NCT06266221
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-05-01
- **Primary completion:** 2027-06-01
- **Final completion:** 2027-11-01
- **Target enrollment:** 96 (ESTIMATED)
- **Last updated:** 2024-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06266221

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06266221, "Severe Erythema Multiforme - CORTICO". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06266221. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*